SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-027226
Filing Date
2024-05-23
Accepted
2024-05-23 07:10:17
Documents
15
Period of Report
2024-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20029704_8k.htm   iXBRL 8-K 70613
2 EXHIBIT 99.1 ef20029704_ex99-1.htm EX-99.1 10208
6 image00001.jpg GRAPHIC 2780
  Complete submission text file 0001140361-24-027226.txt   230814

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atai-20240517.xsd EX-101.SCH 3856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atai-20240517_lab.xml EX-101.LAB 22690
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atai-20240517_pre.xml EX-101.PRE 16546
19 EXTRACTED XBRL INSTANCE DOCUMENT ef20029704_8k_htm.xml XML 4213
Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40493 | Film No.: 24975187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)